Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Special Drug Use-results Surveillance of Scemblix Tablets

NCT05421091

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Anjo, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Kasugai, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 278 locations
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

The EMPATHY Pilot Study

NCT04384848

Conditions
Bone Marrow Diseases, Cancer, Chronic Disease, +12 more
Locations
  • Augusta University, Hematology and Oncology Augusta, Georgia, United States
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center Comprehensive Cancer Center (RHLCCC) Chicago, Illinois, United States
  • Policlinico Sant'Orsola Malpighi - UOC Ematologia - Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO - Azienda Ospedaliera G. Brotzu Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Effect of 2nd Gen TKI in CML

NCT02222272

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Helsinki University Central Hospital Helsinki, Finland
  • University of Freiburg Freiburg im Breisgau, Germany
  • University of Muenster Münster, Germany
View Trial Details
Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

Occupational Status and Hematological Disease

NCT02057185

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti Genzano di Roma, Italy
  • Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy
  • U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy
View Trial Details

Related conditions